1-Hydroxybenzotriazole → 1246761-03-4

HRID 877037노트

반응식

HRID 877037 반응식
[CH3:1][N:2]1[C:7]2=[CH:8][S:9][C:10](C)=[C:6]2[C:5](=[O:12])[N:4]([CH3:13])[C:3]1=[O:14].[F:15][C:16]1[C:21]([C:22]([F:25])([F:24])[F:23])=[C:20]([F:26])[CH:19]=[CH:18][C:17]=1[C:27]1[N:28]=[C:29]([NH2:32])[S:30][CH:31]=1.CCN=C=NC[CH2:39][CH2:40]N(C)C.Cl.C1C=CC2N([OH:54])N=NC=2C=1>CN(C1C=CN=CC=1)C.ClCCCl>[F:15][C:16]1[C:21]([C:22]([F:23])([F:24])[F:25])=[C:20]([F:26])[CH:19]=[CH:18][C:17]=1[C:27]1[N:28]=[C:29]([NH:32][C:39](=[O:54])[CH2:40][C:7]2[C:6]3[C:5](=[O:12])[N:4]([CH3:13])[C:3](=[O:14])[N:2]([CH3:1])[C:10]=3[S:9][CH:8]=2)[S:30][CH:31]=1

참가 물질

7

실험 절차

The title compound was prepared according to the general procedure (Method A) by coupling Intermediate 1 (100 mg, 0.393 mmol) with 4-[2,4-difluoro-3-(trifluoromethyl)phenyl]-1,3-thiazol-2-amine (110 mg, 0.393 mmol) in the presence of EDCI hydrochloride (90 mg, 0.471 mmol), HOBt (16 mg, 0.117 mmol) and DMAP (5 mg, 0.039 mmol) in 1,2 dichloroethane (4 ml) to give 20 mg of the product as a white solid; 1H NMR (300 MHz, DMSO-d6) δ 3.19 (s, 3H), 3.47 (s, 3H), 4.07 (s, 2H), 7.08 (s, 1H), 7.55 (t, J=9.0 Hz, 1H), 7.62 (s, 1H), 8.34 (q, J=6.9 Hz, 1H), 12.50 (br s, 1H); ESI-MS (m/z) 517.09 (M+H)+.

출처 및 근거

ORD 기록
ord-f2bc307977544408a3727d769a85370e
출처 데이터셋
uspto-grants-2015_03
특허 번호
US08987278B2

반응 노트

불러오는 중…